ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, the oncogenic BCR-ABL protein in CML enhances cell survival at least in part through its inhibitory effect on CCN3, resulting in reduced apoptosis and enhanced cell growth.